WELCOME TO JOHNS HOPKINS HEALTH ALERTS!

This free public service from Johns Hopkins Medicine helps keep you up to date on the latest breakthroughs for the most common medical conditions which prevent healthy aging. Browse all the articles via the Health Alert Topics navigation bar on the right, or read the headlines below.


Get the latest news sent straight to your Inbox. Register now for your FREE Johns Hopkins Health Alerts. Check the boxes below for all the topics you are interested in, enter your email address, and click "Send." It's fast, easy, and FREE.   Benefits of Being A Registered User

Enter your email here: (Example: yourname@domain.com)
Please send my alerts as:

We value your privacy and will never rent your email address.Already a Member? Manage your Health Alerts


Johns Hopkins Health Alert

Better Mood Equals Better Glycemic Control

Comments (0)

If you have diabetes, you know how important it is to control your blood glucose and keep it within normal range. But sometimes, depression can get in the way. Now a study in Diabetes Care links the antidepressant Wellbutrin XL with improved control.

Individuals with diabetes who are depressed may benefit from the antidepressant bupropion (Wellbutrin XL), which can lift their spirits and improve blood glucose control, according to an article in Diabetes Care (Volume 30, page 4590).

While similar results have been reported before, lower glucose levels were thought to result from the weight loss and improved self-care that often accompany successful depression treatment. But researchers are now finding that a better mood alone may lead to improved glycemic control over the long haul.

In a two-phase, open-label trial, 93 participants with type 2 diabetes and major depression took Wellbutrin XL, an antidepressant associated with weight loss, for just over two months. Of the 75 volunteers who stayed on Wellbutrin XL for 10 weeks, 84% reported improved mood, weight loss, and better self-care with diet and exercise. At the same time, the participants experienced a 0.5% reduction in HbA1c levels.

Looking at whether these improvements would last if they took the medication longer, a positive mood was most important for keeping glucose under control for another six months, regardless of weight loss or self-care changes.

While the exact mechanisms behind better glycemic control need further study, treating any accompanying depression is clearly important for managing diabetes.

Posted in Diabetes on February 12, 2009


Medical Disclaimer: This information is not intended to substitute for the advice of a physician. Click here for additional information: Johns Hopkins Health Alerts Disclaimer


Notify Me

Would you like us to inform you when we post new Diabetes Health Alerts?

Post a Comment

Comments

Health Alerts registered users may post comments and share experiences here at their own discretion. We regret that questions on individual health concerns to the Johns Hopkins editors cannot be answered in this space.

The views expressed here do not constitute medical advice, and do not represent the position of Johns Hopkins Medicine or Remedy Health Media, LLC, which has no responsibility for any comments posted on this site.


Post a Comment


Already a subscriber?

Login

Forgot your password?

New to Johns Hopkins Health Alerts?

Register to submit your comments.

(example: yourname@domain.com)

(800) 829-0422

Registered Users Log-in:

Forgot Password?

Become a Registered User!
It's fast and FREE!
The Benefits of Being a Registered User

Health Topic Pages

  • Health Alert
  • Special Report

What is this?

XML


Johns Hopkins’ Diabetes Bestsellers

Our Featured Title:

Johns Hopkins White Paper 2011: Diabetes


Related Titles: